Navigation Links
SuperArray Bioscience Changes Name to SABiosciences and Moves Into New Larger Facility on Verge of Tenth Anniversary
Date:7/23/2008

FREDERICK, Md., July 23 /PRNewswire-USNewswire/ -- SuperArray Bioscience Corporation announced today it has changed its name to SABiosciences Corporation and moved to a brand new facility three times larger than the previous location. The changes reflect both its phenomenal growth over the last few years and its continuing expansion into other additional technologies besides gene expression analysis.

"We are not just a microarray company anymore," said Dave Martz, Vice President of Sales and Marketing at SABiosciences. "We are now and will continue to become so much more. SuperArray developed a solid reputation for delivering pathway-focused content for gene expression analysis, first with its hybridization-based microarrays and then most recently and much more successfully with real-time PCR Arrays. However, to provide our vision of a systems biology approach in a post-genomic era, SABiosciences now also offers gene function analysis solutions such as RNA interference, ELISA kits, cell-based reporter assays, as well as chromatin immunoprecipitation and other products for epigenomics research."

The move and name change occurs on the heels of receiving the Tech Council of Maryland Frederick County Firm of the Year Award in 2007 and just before their tenth anniversary as an incorporated company. Rapid growth and continually aggressive revenue projections allowed and indeed necessitated more personnel and capital equipment. After quickly outgrowing their currently available space of 18,000 square feet, the company moves to a new building with 43,000 square feet that supports 150 full-time employees. The company remains in Frederick, Maryland, only a few blocks away in the newly developed Westview South Office Research Center.

"To accommodate our rapid business growth and to better serve our customers, we built this new facility with state of the art R&D lab space, molecular and cell biology instruments, particle-free clean rooms," Martz continued. "As we approach our tenth anniversary this fall, we are very excited about the opportunities for our continued success that the new location will provide us. The name change better reflects our business model and vision for the future. We will continue bringing cutting edge technologies into every biological research laboratory with relevant biological content."

About SABiosciences Corporation

SABiosciences Corporation, a privately held biotechnology company founded in 1998, envisions a new and systematic approach to biological research in the post-genomic era. We have developed a broad portfolio of innovative and cost-effective research tools based on current knowledge and understanding of important biological pathways that merge the benefits of hypothesis-driven and discovery-based research. Our goal is to provide practical research tools that accelerate, simplify and improve life science research.


'/>"/>
SOURCE SABiosciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Seahorse Bioscience Receives Poster Award from the European Association for the Study of Obesity
2. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
3. Monogram Biosciences Announces Second Quarter 2008 Financial Results Conference Call
4. PURE Bioscience Announces Distribution Agreement With Orchem Corporation
5. Pacific Biosciences Raises $100 Million to Fund Commercial Product Development
6. PURE Bioscience CEO to Ring NASDAQ Closing Bell
7. Ardea Biosciences Advances RDEA806 Into Phase 2a Proof-of-Concept Study for Gout
8. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
9. Cell Biosciences Strengthens Management Team
10. Monogram Biosciences to Present at the Collins Stewart Fourth Annual Growth Conference
11. Abbott Invests Additional $20M in Isis Subsidiary Ibis Biosciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ON (PRWEB) , ... June 23, 2016 , ... STACS ... DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as ... the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... Andrew D Zelenetz ... Published recently in Oncology ... touchONCOLOGY, Andrew D Zelenetz , discusses the ... is placing an increasing burden on healthcare systems ... With the patents on many biologics expiring, interest ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
Breaking Biology Technology:
(Date:6/1/2016)... , June 1, 2016 ... in Election Administration and Criminal Identification to Boost Global ... a recently released TechSci Research report, " Global Biometrics ... Region, Competition Forecast and Opportunities, 2011 - 2021", the ... billion by 2021, on account of growing security concerns ...
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
Breaking Biology News(10 mins):